Anti-S. aureus phages(Phaxiam Therapeutics)

N/A

Report date: 2026/04/07 20:00:20

Base Information

Drug NameAnti-S. aureus phages(Phaxiam Therapeutics)
Drug Alias NameAnti-Klebsiella phages(Phaxiam Therapeutics)anti- Staphylococcus aureus bacteriophagesPP1493
ClassificationBiologics > Bacteriophages
Mechanisms of ActionCell death stimulants
TargetsUpdating
Therapy Area/IndicationsProsthesis-Related InfectionsStaphylococcal InfectionsKlebsiella Infections +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesPhaxiam Therapeutics SA
China Registration ClassN/A

Develop Information

Active CompaniesPhaxiam Therapeutics SA
Inactive CompaniesN/A
Active IndicationsProsthesis-Related InfectionsStaphylococcal InfectionsKlebsiella Infections +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A